| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $989.5M | +12.5% |
| Cost of Revenue | $716.9M | +18.1% |
| Gross Profit | $272.7M | +0.0% |
| R&D Expense | $6.3M | -3.0% |
| SG&A Expense | $79.6M | -0.7% |
| Operating Income | $169.2M | -1.9% |
| Pre-tax Income | $105.7M | -8.3% |
| Income Tax | -$20.3M | -24.5% |
| Net Income | $123.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $147.4M | +56.2% |
| Accounts Receivable | $164.8M | +0.4% |
| Inventory | $45.3M | +18.8% |
| Current Assets | $597.8M | +9.3% |
| Total Assets | $6.25B | +10.2% |
| Current Liabilities | $738.4M | +23.5% |
| Long-term Debt | $2.66B | +13.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $335.1M | -18.5% |
| Capital Expenditures | $619.8M | +27.1% |
| Investing Cash Flow | -$726.4M | +6.9% |
| Financing Cash Flow | $465.7M | +61.8% |
| Free Cash Flow | -$284.7M | -270.9% |
| +0.1% |
| EPS (Basic) | $2.04 | -0.5% |
| EPS (Diluted) | $2.02 | -1.0% |
| Total Liabilities |
| $3.56B |
| +14.5% |
| Stockholders' Equity | $2.54B | +4.9% |